Depomed (DEPO) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Net income (loss): -12.89M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Financial Fact:
Net income (loss): -12.89M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q1 EPS of $0.12, $0.05 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $104.8 million versus the consensus estimate of $107.1 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- First Bancorp. (FBNC) Misses Q1 EPS by 2c
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
